Lyssavirus matrix protein induces a poptosis by a TRAIL-dependent mechanism involving caspase-8 activation

被引:62
作者
Kassis, R
Larrous, F
Estaquier, J
Bourhy, H
机构
[1] Inst Pasteur, Lab Rage, F-75724 Paris 15, France
[2] Inst Pasteur, Unite Rech & Expertise Physiopathol Infect Lentiv, F-75724 Paris 15, France
关键词
D O I
10.1128/JVI.78.12.6543-6555.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lyssaviruses, which are members of the Rhabdoviridae family, induce apoptosis, which plays an important role in the neuropathogenesis of rabies. However, the mechanisms by which these viruses mediate neuronal apoptosis have not been elucidated. Here we demonstrate that the early induction of apoptosis in a model of lyssavirus-infected neuroblastoma cells involves a TRAIL-dependent pathway requiring the activation of caspase-8 but not of caspase-9 or caspase-10. The activation of caspase-8 results in the activation of caspase-3 and caspase-6, as shown by an increase in the cleavage of the specific caspase substrate in lyssavirus-infected cells. However, neither caspase-1 nor caspase-2 activity was detected during the early phase of infection. Lyssavirus-mediated cell death involves an interaction between TRAIL receptors and TRAIL, as demonstrated by experiments using neutralizing antibodies and soluble decoy TRAIL-R1/R2 receptors. We also demonstrated that the decapsidation and replication of lyssavirus are essential for inducing apoptosis, as supported by UV inactivation, cycloheximide treatment, and the use of bafilomycin A1 to inhibit endosomal acidification. Transfection of cells with the matrix protein induced apoptosis using pathways similar to those described in the context of viral infection. Furthermore, our data suggest that the matrix protein of lyssaviruses plays a major role in the early induction of TRAIL-mediated apoptosis by the release of a soluble, active form of TRAIL. In our model, Fas ligand (CD95L) appears to play a limited role in lyssavirus-mediated neuroblastoma cell death. Similarly, tumor necrosis factor alpha does not appear to play an important role.
引用
收藏
页码:6543 / 6555
页数:13
相关论文
共 80 条
[11]  
Cheema ZF, 1999, J NEUROSCI, V19, P1754
[12]   Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures [J].
Chiou, PP ;
Kim, CH ;
Ormonde, P ;
Leong, JAC .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7619-7627
[13]   Reovirus-induced apoptosis is mediated by TRAIL [J].
Clarke, P ;
Meintzer, SM ;
Gibson, S ;
Widmann, C ;
Garrington, TP ;
Johnson, GL ;
Tyler, KL .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8135-8139
[14]   Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection [J].
Clarke, P ;
Meintzer, SM ;
Spalding, AC ;
Johnson, GL ;
Tyler, KL .
ONCOGENE, 2001, 20 (47) :6910-6919
[15]   Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[16]   Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus [J].
Desforges, M ;
Despars, G ;
Bárard, S ;
Gosselin, M ;
McKenzie, MO ;
Lyles, DS ;
Talbot, PJ ;
Poliquin, L .
VIROLOGY, 2002, 295 (01) :63-73
[17]   Induction of TRAIL-mediated glioma cell death by human T cells [J].
Dörr, J ;
Waiczies, S ;
Wendling, U ;
Seeger, B ;
Zipp, F .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 122 (1-2) :117-124
[18]   INVOLVEMENT OF AN ICE-LIKE PROTEASE IN FAS-MEDIATED APOPTOSIS [J].
ENARI, M ;
HUG, H ;
NAGATA, S .
NATURE, 1995, 375 (6526) :78-81
[19]   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50
[20]   T-HELPER TYPE 1/T HELPER TYPE-2 CYTOKINES AND T-CELL DEATH - PREVENTIVE EFFECT OF INTERLEUKIN-12 ON ACTIVATION-INDUCED AND CD95 (FAS/APO-1)-MEDIATED APOPTOSIS OF CD4(+) T-CELLS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS [J].
ESTAQUIER, J ;
IDZIOREK, T ;
ZOU, WP ;
EMILIE, D ;
FARBER, CM ;
BOUREZ, JM ;
AMEISEN, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1759-1767